journal article·2021-12-08Open access

The Metabolic Stability of Antimicrobial Peptides IK8 in Plasma and Liver S9

Yingying Mao, Shaojun Zhou, Mingcheng Xu, Su Zeng, Weimin Fan, Lushan Yu, Nengming Lin

Applied Sciences· Volume 11· Issue 24

Abstract

In the face of mounting global antibiotic resistance, which has become a critical clinical problem, antimicrobial peptides (AMPs) have received considerable interest as new therapeutics with the efficacy for the treatment of multidrug-resistant (MDR) infections due to their novel mechanism. However, certain inherent shortcomings such as instability seriously limit their systemic applications in the clinic. In this study, we intend to clarify the connection between three configurations of IK8 and their stability in plasma and liver S9 of various species by confirming the metabolites. The structural information of these metabolites was scanned and identified using HPLC and Q-TOF, respectively. The results found that IK8-D exhibits superior stability, compared with IK8-2D and IK8-L in plasma and liver S9 incubation, which indicated D- type amino acids could significantly increase the stability of antimicrobial peptides.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Antimicrobial Peptides and Activities · Biochemical and Structural Characterization · Antibiotic Resistance in Bacteria

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China

Program of Innovative Cancer Therapeutics, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, College of Medicine, Zhejiang University, Hangzhou 310003, China

Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Department of Clinical Pharmacy, Zhejiang University School of Medicine, Hangzhou 310006, China

References (23)

Show source-provided references
1. The antimicrobial peptides and their potential clinical applications
2. The negative impact of antibiotic resistance
3. Rima, M., Rima, M., Fajloun, Z., Sabatier, J.M., Bechinger, B., and Naas, T. (2021). Antimicrobial peptides: A potent alternative to antibiotics. Antibiotics, 10.10.3390/antibiotics10091095 ↗
4. Copsin, a novel peptide-based fungal antibiotic interfering with the peptidoglycan synthesis10.1074/jbc.M114.599878 ↗
5. Wu, Q., Patočka, J., and Kuča, K. (2018). Insect antimicrobial peptides, a mini review. Toxins, 10.10.3390/toxins10110461 ↗
6. Discovery and biosynthetic investigation of a new antibacterial dehydrated non-ribosomal tripeptide10.1002/anie.202012902 ↗
7. The value of antimicrobial peptides in the age of resistance10.1016/S1473-3099(20)30327-3 ↗
8. Erdem Büyükkiraz, M., and Kesmen, Z. (2021). Antimicrobial peptides (AMPs): A promising class of antimicrobial compounds. J. Appl. Microbiol., Online ahead of print.10.1111/jam.15314 ↗
9. Kumar, P., Kizhakkedathu, J.N., and Straus, S.K. (2018). Antimicrobial peptides: Diversity, mechanism of action and strategies to improve the activity and biocompatibility in vivo. Biomolecules, 8.10.3390/biom8010004 ↗
10. Biodegradable antimicrobial polycarbonates with in vivo efficacy against multidrug-resistant MRSA systemic infection10.1002/adhm.201500471 ↗
11. Mini review on antimicrobial peptides, sources, mechanism and recent applications10.2174/18755305MTAwENDE80 ↗
12. An antimicrobial peptide that inhibits translation by trapping release factors on the ribosome10.1038/nsmb.3439 ↗
13. Antimicrobial peptides: Mechanism of action, activity and clinical potential
14. Hansen, I., Lövdahl, T., Simonovic, D., Hansen, K., Andersen, A.J.C., Devold, H., Richard, C.S.M., Andersen, J.H., Strøm, M.B., and Haug, T. (2020). Antimicrobial activity of small synthetic peptides based on the marine peptide turgencin A: Prediction of antimicrobial peptide sequences in a natural peptide and strategy for optimization of potency. Int. J. Mol. Sci., 21.10.3390/ijms21155460 ↗
15. Mechanisms of action for antimicrobial peptides with antibacterial and antibiofilm functions10.3389/fmicb.2019.02866 ↗
16. Development of a novel hybrid antimicrobial peptide for targeted killing of Pseudomonas aeruginosa10.1016/j.ejmech.2019.111814 ↗
17. Review: Lessons learned from clinical trials using antimicrobial peptides (AMPs)10.3389/fmicb.2021.616979 ↗
18. Antimicrobial peptides: An emerging category of therapeutic agents10.3389/fcimb.2016.00194 ↗
19. A macromolecular approach to eradicate multidrug resistant bacterial infections while mitigating drug resistance onset10.1038/s41467-018-03325-6 ↗
20. Falciani, C., Lozzi, L., Pollini, S., Luca, V., Carnicelli, V., Brunetti, J., Lelli, B., Bindi, S., Scali, S., and Di Giulio, A. (2012). Isomerization of an antimicrobial peptide broadens antimicrobial spectrum to gram-positive bacterial pathogens. PLoS ONE, 7.10.1371/journal.pone.0046259 ↗
21. Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles10.1016/j.biomaterials.2013.10.053 ↗
22. Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of synthetic antimicrobial peptides10.1038/s41598-020-69995-9 ↗
23. Short Synthetic β-Sheet Antimicrobial Peptides for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Burn Wound Infections10.1002/adhm.201601134 ↗